Therapeutics | Important Update to Author Guidelines: New “Highlights” Section Required

Therapeutics (ISSN: 2813-9909) is committed to enhancing the visibility, accessibility, and impact of the research we publish. To help readers quickly identify and understand the core contributions of your work, we are introducing a new requirement for all article submissions.

Effective immediately, all new manuscripts are recommended to include a “Highlights” Section.

What are “Highlights”?
This is an optional Section in Therapeutics whose goal is to increase the discoverability and readability of the article via search engines and other scholars. Highlights should not be a copy of the abstract, but a simple text allowing the reader to quickly and simply find out what the article is about and what can be cited from it. Each of these parts should comprise up to two bullet points.

What are the main findings?

First bullet;
Second bullet.

What are the implications of the main findings?

First bullet;
Second bullet.

Please download the updated “Instructions for Authors” and template from the link below: https://www.mdpi.com/journal/therapeutics/instructions.

We appreciate your cooperation in implementing this new requirement, which will significantly benefit the broader scientific community. Thank you for choosing to publish with Therapeutics.